Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0X9KB
|
|||
Drug Name |
ACER-002
|
|||
Indication | Ehlers-Danlos syndrome [ICD-11: LD28.1] | Phase 3 | [1] | |
Company |
Acer Therapeutics Cambridge, MA
|
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.